Kistler-Tiffany Companies’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $27.5K | Hold |
214
| – | – | ﹤0.01% | 576 |
|
|
2023
Q1 | $24.9K | Hold |
214
| – | – | ﹤0.01% | 523 |
|
|
2022
Q4 | $24.2K | Buy |
214
+150
| +234% | +$17K | 0.01% | 504 |
|
|
2022
Q3 | $5K | Hold |
64
| – | – | ﹤0.01% | 674 |
|
|
2022
Q2 | $5K | Hold |
64
| – | – | ﹤0.01% | 661 |
|
|
2022
Q1 | $8K | Hold |
64
| – | – | ﹤0.01% | 619 |
|
|
2021
Q4 | $9K | Hold |
64
| – | – | ﹤0.01% | 602 |
|
|
2021
Q3 | $9K | Sell |
64
-20
| -24% | -$2.81K | ﹤0.01% | 596 |
|
|
2021
Q2 | $9K | Hold |
84
| – | – | ﹤0.01% | 571 |
|
|
2021
Q1 | $8K | Hold |
84
| – | – | ﹤0.01% | 543 |
|
|
2020
Q4 | $8K | Hold |
84
| – | – | ﹤0.01% | 516 |
|
|
2020
Q3 | $9K | Hold |
84
| – | – | ﹤0.01% | 485 |
|
|
2020
Q2 | $9K | Buy |
+84
| New | +$9K | ﹤0.01% | 457 |
|